ADJUVANT REGORAFENIB IN STAGE IV COLORECTAL CANCER (CRC) AFTER CURATIVE TREATMENT OF LIVER METASTASES: A PHASE III RANDOMIZED, PLACEBO-CONTROLLED STUDY (COAST)

被引：0

作者：

Eric, Van Cutsem ^{[1
]}

Takayuki, Yoshino ^{[2
]}

Xu Rui-Hua ^{[3
]}

John, Zalcberg ^{[4
]}

Daniel, Sargent ^{[5
,6
]}

Michael, Choti ^{[7
]}

Mark, Rutstein ^{[8
]}

Lisa, Cupit ^{[8
]}

Iris, Kuss ^{[9
]}

Axel, Grothey ^{[10
]}

机构：

[1] UZ Leuven, Leuven Canc Inst, Leuven, Belgium

[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[3] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China

[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[5] Mayo Clin, Rochester, MN USA

[6] Mayo Canc Ctr, Rochester, MN USA

[7] UT Southwestern Med Ctr, Dallas, TX USA

[8] Bayer Healthcare, Whippany, NJ USA

[9] Bayer Pharma AG, Berlin, Germany

[10] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA

来源：

ANNALS OF ONCOLOGY | 2014年 / 25卷

关键词：

D O I：

10.1093/annonc/mdu165.261

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P - 0266

引用

页码：92 / 92

页数：1

共 50 条

[41] LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases--a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
Carl Christoph Schimanski
Markus Möhler
Michael Schön
Eric van Cutsem
Richard Greil
Wolf Otto Bechstein
Susanna Hegewisch-Becker
Götz von Wichert
Matthias Vöhringer
Michael Heike
Volker Heinemann
Marc Peeters
Stephan Kanzler
Stefan Kasper
Friedrich Overkamp
Jan Schröder
Daniel Seehofer
Frank Kullmann
Bernhard Linz
Irene Schmidtmann
Victoria Smith-Machnow
Ines Gockel
Hauke Lang
Peter R Galle
BMC Cancer, 12
[42] A double-blind, placebo-controlled, randomized phase IIa trial, evaluating the effect of curcumin for the treatment of cancer anorexia-cachexia syndrome in patients with stage III-IV head and neck cancer (CurChexia)
Thambamroong, T.
Saichaemchan, S.
Seetalarom, K.
Prasongsook, N.
ANNALS OF ONCOLOGY, 2021, 32 : S1178 - S1178
[43] A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
Timothy J. Vreeland
Guy T. Clifton
Diane F. Hale
Robert C. Chick
Annelies T. Hickerson
Jessica L. Cindass
Alexandra M. Adams
Phillip M. Kemp Bohan
Robert H. I. Andtbacka
Adam C. Berger
James W. Jakub
Jeffrey J. Sussman
Alicia M. Terando
Thomas Wagner
George E. Peoples
Mark B. Faries
Annals of Surgical Oncology, 2021, 28 : 6126 - 6137
[44] A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
Vreeland, Timothy J.
Clifton, Guy T.
Hale, Diane F.
Chick, Robert C.
Hickerson, Annelies T.
Cindass, Jessica L.
Adams, Alexandra M.
Bohan, Phillip M. Kemp
Andtbacka, Robert H. I.
Berger, Adam C.
Jakub, James W.
Sussman, Jeffrey J.
Terando, Alicia M.
Wagner, Thomas
Peoples, George E.
Faries, Mark B.
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6126 - 6137
[45] Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
Xu, Rui-Hua
Shen, Lin
Wang, Ke-Ming
Wu, Gang
Shi, Chun-Mei
Ding, Ke-Feng
Lin, Li-Zhu
Wang, Jin-Wan
Xiong, Jian-Ping
Wu, Chang-Ping
Li, Jin
Liu, Yun-Peng
Wang, Dong
Ba, Yi
Feng, Jue-Ping
Bai, Yu-Xian
Bi, Jing-Wang
Ma, Li-Wen
Lei, Jian
Yang, Qing
Yu, Hao
CHINESE JOURNAL OF CANCER, 2017, 36
[46] A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
Cohn, A. L.
Tabernero, J.
Maurel, J.
Nowara, E.
Sastre, J.
Chuah, B. Y. S.
Kopp, M. V.
Sakaeva, D. D.
Mitchell, E. P.
Dubey, S.
Suzuki, S.
Hei, Y-J
Galimi, F.
McCaffery, I.
Pan, Y.
Loberg, R.
Cottrell, S.
Choo, S-P
ANNALS OF ONCOLOGY, 2013, 24 (07) : 1777 - 1785
[47] A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
Ychou, M.
Hohenberger, W.
Thezenas, S.
Navarro, M.
Maurel, J.
Bokemeyer, C.
Shacham-Shmueli, E.
Rivera, F.
Choi, C. Kwok-Keung
Santoro, A.
ANNALS OF ONCOLOGY, 2009, 20 (12) : 1964 - 1970
[48] Efficacy of aspirin for stage III colorectal cancer: A randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).
Takashima, Atsuo
Miyamoto, Kenichi
Sato, Yuya
Okita, Natsuko
Shiozawa, Manabu
Yamaguchi, Shigeki
Inada, Ryo
Nishizawa, Yusuke
Ohue, Masayuki
Takiguchi, Nobuhiro
Mizusawa, Junki
Katayama, Hiroshi
Nakamura, Kenichi
Shibata, Taro
Fukuda, Haruhiko
Shimada, Yasuhiro
Kanemitsu, Yukihide
Hamaguchi, Tetsuya
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[49] Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial)
Miyamoto, Kenichi
Takashima, Atsuo
Mizusawa, Junki
Sato, Yuya
Shimada, Yasuhiro
Katayama, Hiroshi
Nakamura, Kenichi
Shibata, Taro
Fukuda, Haruhiko
Shida, Dai
Kanemitsu, Yukihide
Hamaguchi, Tetsuya
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (10) : 985 - 989
[50] Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Moore, Kathleen N.
Bookman, Michael
Sehouli, Jalid
Miller, Austin
Anderson, Charles
Scambia, Giovanni
Myers, Tashanna
Taskiran, Cagatay
Robison, Katina
Maenpaa, Johanna
Willmott, Lyndsay
Colombo, Nicoletta
Thomes-Pepin, Jessica
Liontos, Michalis
Gold, Michael A.
Garcia, Yolanda
Sharma, Sudarshan K.
Darus, Christopher J.
Aghajanian, Carol
Okamoto, Aikou
Wu, Xiaohua
Safin, Rustem
Wu, Fan
Molinero, Luciana
Maiya, Vidya
Khor, Victor K.
Lin, Yvonne G.
Pignata, Sandro
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (17) : 1842 - +

← 1 2 3 4 5 →